Literature DB >> 3696741

Idiopathic trigeminal neuralgia: sensory features and pain mechanisms.

R Dubner1, Y Sharav, R H Gracely, D D Price.   

Abstract

We present a case report of a patient with the typical sensory features of idiopathic trigeminal neuralgia (ITN). The pain was elicited by innocuous stimuli, summated with repeated stimulation, radiated outside the stimulus zone, referred to a distant site, persisted beyond the period of stimulation, and exhibited a variable refractory period. Unusual sensory features included multiple trigger zones that changed over time and involved all 3 trigeminal divisions. Our sensory evaluation indicated that the pain was evoked by repetitive activation of rapidly adapting, A beta, low-threshold mechanoreceptive afferents. However, activation of such mechanoreceptive afferents alone never produces pain in normal situations and often leads to a suppression of pain responsivity. The findings support the idea that the mechanism of pain in ITN involves pathophysiological mechanisms in the central nervous system. Our hypothesis is that structural and functional changes in the trigeminal system result in an alteration in the receptive field organization of wide-dynamic-range (WDR) neurons. There appears to be an alteration in the surround inhibition mechanism of these neurons leading to an expansion of their touch receptive fields. This results in touch stimuli producing activity in WDR neurons that mimics the activity produced under normal conditions by noxious stimuli. Since WDR neurons participate in the encoding of the perceived intensity of noxious stimuli, a series of punctate tactile stimuli are now perceived as localized, pin-prick or electric shock-like sensations. Similar pathophysiological mechanisms may explain, in part, the pain of peripheral neuropathies associated with postherpetic neuralgia, diabetes and causalgia.

Entities:  

Mesh:

Year:  1987        PMID: 3696741     DOI: 10.1016/0304-3959(87)90003-0

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  13 in total

1.  Mechanical and heat hyperalgesia highly predict clinical pain intensity in patients with chronic musculoskeletal pain syndromes.

Authors:  Roland Staud; Elizabeth E Weyl; Donald D Price; Michael E Robinson
Journal:  J Pain       Date:  2012-06-26       Impact factor: 5.820

Review 2.  Measuring pain in the clinic.

Authors:  R H Gracely
Journal:  Anesth Prog       Date:  1990 Mar-Jun

Review 3.  Problems in the differential diagnosis of chronic pain.

Authors:  K L Casey
Journal:  Anesth Prog       Date:  1990 Mar-Jun

4.  Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis.

Authors:  G Broggi; P Ferroli; A Franzini; D Servello; I Dones
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-01       Impact factor: 10.154

Review 5.  Predictors of clinical pain intensity in patients with fibromyalgia syndrome.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

6.  Idiopathic and symptomatic trigeminal pain.

Authors:  G Cruccu; M Leandri; M Feliciani; M Manfredi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

7.  [Anticonvulsant agents in neuralgic pain.].

Authors:  I Jurna; M Zenz
Journal:  Schmerz       Date:  1992-06       Impact factor: 1.107

Review 8.  Treatment strategy for trigeminal neuralgia: a thirty years experience.

Authors:  Giovanni Broggi; Paolo Ferroli; Angelo Franzini
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

Review 9.  Predictors of clinical pain intensity in patients with fibromyalgia syndrome.

Authors:  Roland Staud
Journal:  Curr Pain Headache Rep       Date:  2005-10

Review 10.  Trigeminal Neuralgia, Glossopharyngeal Neuralgia, and Myofascial Pain Dysfunction Syndrome: An Update.

Authors:  Mohammad Khan; Shamima Easmin Nishi; Siti Nazihahasma Hassan; Md Asiful Islam; Siew Hua Gan
Journal:  Pain Res Manag       Date:  2017-07-30       Impact factor: 3.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.